PATENT CLAIM ANALYSIS

Application Number: 15776880
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "266300"]

Abstract:
Methods for prophylactically treating a stress-induced affective disorder or stress-induced psychopathology in a subject are provided. Also provided are methods for inducing and/or enhancing stress resilience in a subject. In certain embodiments, an effective amount, of an antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptor, such as ketamine, or a pharmaceutically acceptable salt or derivative thereof, is administered to a subject prior to a stressor.

Claim (Index 24):
The method of  claim 1 , wherein the pharmaceutical composition is administered in a booster series.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 93.0
- Lexical Diversity: 1.45098
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15021003', '15849698', '14974576', '15320952', '15052110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7808097761013469
- 35 USC 102 Novelty (BERT): 0.5327268954187021
- Combined Prediction Score: 0.7560014880330825
- Mean Citation Score: 307.319458
- Max Citation Score: 353.25623
- Similarity Product: 222.5314202890444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test